PT720483E - Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demencia - Google Patents
Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demenciaInfo
- Publication number
- PT720483E PT720483E PT94928538T PT94928538T PT720483E PT 720483 E PT720483 E PT 720483E PT 94928538 T PT94928538 T PT 94928538T PT 94928538 T PT94928538 T PT 94928538T PT 720483 E PT720483 E PT 720483E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- growth hormone
- dementia
- drug
- manufacture
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- 208000014644 Brain disease Diseases 0.000 title 1
- 206010012289 Dementia Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 230000000302 ischemic effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 2
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 102000004374 Insulin-like growth factor binding protein 3 Human genes 0.000 abstract 1
- 108090000965 Insulin-like growth factor binding protein 3 Proteins 0.000 abstract 1
- 102000013275 Somatomedins Human genes 0.000 abstract 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9303068A SE9303068D0 (sv) | 1993-09-21 | 1993-09-21 | New use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT720483E true PT720483E (pt) | 2004-08-31 |
Family
ID=20391162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94928538T PT720483E (pt) | 1993-09-21 | 1994-09-21 | Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demencia |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5736515A (pt) |
| EP (1) | EP0720483B1 (pt) |
| JP (1) | JPH09502973A (pt) |
| AT (1) | ATE263573T1 (pt) |
| AU (1) | AU683306B2 (pt) |
| CA (1) | CA2168570C (pt) |
| DE (1) | DE69433687T2 (pt) |
| DK (1) | DK0720483T3 (pt) |
| ES (1) | ES2218529T3 (pt) |
| NZ (1) | NZ274025A (pt) |
| PT (1) | PT720483E (pt) |
| SE (1) | SE9303068D0 (pt) |
| WO (1) | WO1995008345A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514937B1 (en) | 1997-02-25 | 2003-02-04 | Celtrix Pharmaceuticals, Inc. | Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3 |
| US6025368A (en) * | 1997-02-25 | 2000-02-15 | Celtrix Pharmaceuticals, Inc. | Method for treating the symptoms of chronic stress-related disorders using IGF |
| US6015786A (en) * | 1997-02-25 | 2000-01-18 | Celtrix Pharmaceuticals, Inc. | Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
| US7304029B1 (en) | 1998-09-03 | 2007-12-04 | Neuren Pharmaceuticals Ltd. | Neuroprotective effect of growth hormone |
| EP1149583A3 (en) * | 2000-04-13 | 2001-11-14 | Pfizer Products Inc. | Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues |
| NZ544695A (en) * | 2003-07-29 | 2008-11-28 | Ares Trading Sa | Use of human growth hormone in multiple system atrophy |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2974088A (en) * | 1958-07-18 | 1961-03-07 | Merck & Co Inc | Method of preparing growth hormone |
| US3118815A (en) * | 1959-09-28 | 1964-01-21 | Upjohn Co | Growth hormone and recovery thereof |
| CA1224432A (en) * | 1982-08-17 | 1987-07-21 | Gary N. Buell | Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield |
| US4521409A (en) * | 1983-10-03 | 1985-06-04 | Cornell Research Foundation, Inc. | Use of growth hormone to enhance ruminant mammary development |
| JPS62500857A (ja) * | 1985-01-28 | 1987-04-09 | 朴 承文 | 車輌の車輪点灯装置 |
| US4670249A (en) * | 1985-04-12 | 1987-06-02 | International Minerals & Chemical Corp. | Growth-promoting compositions |
| US4786501A (en) * | 1985-07-15 | 1988-11-22 | International Minerals & Chemical Corp. | Cylindrical implants for the controlled release of growth hormones |
| IL79681A (en) * | 1985-08-12 | 1991-06-10 | Int Minerals & Chem Corp | Transition metal complexes of growth hormones and their prolonged release compositions |
| US4977140A (en) * | 1985-08-23 | 1990-12-11 | Eli Lilly And Company | Injectable sustained release formulation |
| IL79765A (en) * | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
| US4857506A (en) * | 1987-01-12 | 1989-08-15 | American Cyanamid Company | Sustained release growth hormone compositions for parenteral administration and their use |
| US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
| NZ223842A (en) * | 1988-03-10 | 1991-07-26 | Amgen Inc | Porcine growth hormone analogues, production using genetic engineering and compositions for promoting growth in mammals |
-
1993
- 1993-09-21 SE SE9303068A patent/SE9303068D0/xx unknown
-
1994
- 1994-09-21 PT PT94928538T patent/PT720483E/pt unknown
- 1994-09-21 ES ES94928538T patent/ES2218529T3/es not_active Expired - Lifetime
- 1994-09-21 DK DK94928538T patent/DK0720483T3/da active
- 1994-09-21 WO PCT/SE1994/000875 patent/WO1995008345A1/en active IP Right Grant
- 1994-09-21 CA CA002168570A patent/CA2168570C/en not_active Expired - Fee Related
- 1994-09-21 AU AU77933/94A patent/AU683306B2/en not_active Ceased
- 1994-09-21 JP JP7509721A patent/JPH09502973A/ja active Pending
- 1994-09-21 EP EP94928538A patent/EP0720483B1/en not_active Expired - Lifetime
- 1994-09-21 NZ NZ274025A patent/NZ274025A/en not_active IP Right Cessation
- 1994-09-21 US US08/602,728 patent/US5736515A/en not_active Expired - Lifetime
- 1994-09-21 AT AT94928538T patent/ATE263573T1/de active
- 1994-09-21 DE DE69433687T patent/DE69433687T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU683306B2 (en) | 1997-11-06 |
| SE9303068D0 (sv) | 1993-09-21 |
| DE69433687D1 (de) | 2004-05-13 |
| ATE263573T1 (de) | 2004-04-15 |
| CA2168570A1 (en) | 1995-03-30 |
| JPH09502973A (ja) | 1997-03-25 |
| NZ274025A (en) | 2005-03-24 |
| US5736515A (en) | 1998-04-07 |
| ES2218529T3 (es) | 2004-11-16 |
| CA2168570C (en) | 2009-04-07 |
| DE69433687T2 (de) | 2005-03-17 |
| AU7793394A (en) | 1995-04-10 |
| EP0720483B1 (en) | 2004-04-07 |
| WO1995008345A1 (en) | 1995-03-30 |
| EP0720483A1 (en) | 1996-07-10 |
| DK0720483T3 (da) | 2004-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230112T2 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
| EP0798000A3 (en) | Treating disorders by application of insulin-like growth factors and analogs | |
| PT95117A (pt) | Metodo para o tratamento da ejaculacao precoce utilizando sertralina | |
| EE03148B1 (et) | Kristallilise magneesiumomeprasooli ravimvorm, selle valmistamise protsess ja kasutamine | |
| DE69533112D1 (de) | Verwendung von flavolignanen zur herstellung von medikamenten mit antiproliferativer aktivität in gebärmutter,brust,eierstöcken | |
| ATE113834T1 (de) | Zusammensetzung zur behandlung der schizophrenie. | |
| DE69132688D1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| ATE151293T1 (de) | Igf-i zur verbesserung der neuronale lage | |
| YU209288A (en) | Process for producing compound for treating, which contains azelastin for use in nose and/or eye | |
| ES2168302T3 (es) | Tratamiento de trastornos y estados neuromusculares con toxina botulinica de serotipo e. | |
| PT720483E (pt) | Utilizacao de hormona de crescimento no fabrico de um medicamento para o tratamento de lesao cerebral isquemica e demencia | |
| CA2074166A1 (en) | Method for treating intestinal diseases | |
| DE69332541T2 (de) | Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie | |
| ATE235237T1 (de) | Sertralin zur behandlung von post-myocard-infarkt-patienten | |
| DE69026087D1 (de) | Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung | |
| ATE236652T1 (de) | Igf-i and -ii zur behandlung von krankheiten im zentralnervensystem | |
| PT914122E (pt) | Metodo para o tratamento e prevencao de disturbios neurodegenerativos atraves da administracao de uma tiazolidinona | |
| SE9501773D0 (sv) | New use | |
| UA29106A (uk) | Спосіб лікування вібраційної хвороби | |
| UA6640A (uk) | Спосіб прогнозування загострення супутнього захворювання при активізації основної патології |